Literature DB >> 10617731

A trade-off analysis of routine newborn circumcision.

D A Christakis1, E Harvey, D M Zerr, C Feudtner, J A Wright, F A Connell.   

Abstract

BACKGROUND: The risks associated with newborn circumcision have not been as extensively evaluated as the benefits.
OBJECTIVES: The goals of this study were threefold: 1) to derive a population-based complication rate for newborn circumcision; 2) to calculate the number needed to harm for newborn circumcision based on this rate; and 3) to establish trade-offs based on our complication rates and published estimates of the benefits of circumcision including the prevention of urinary tract infections and penile cancer.
METHODS: Using the Comprehensive Hospital Abstract Reporting System for Washington State, we retrospectively examined routine newborn circumcisions performed over 9 years (1987-1996). We used International Classification of Diseases, Ninth Revision codes to identify both circumcisions and complications and limited our analyses to children without other surgical procedures performed during their initial birth hospitalization.
RESULTS: Of 354, 297 male infants born during the study period, 130,475 (37%) were circumcised during their newborn stay. Overall 287 (.2%) of circumcised children and 33 (.01%) of uncircumcised children had complications potentially associated with circumcision coded as a discharge diagnosis. Based on our findings, a complication can be expected in 1 out every 476 circumcisions. Six urinary tract infections can be prevented for every complication endured and almost 2 complications can be expected for every case of penile cancer prevented.
CONCLUSIONS: Circumcision remains a relatively safe procedure. However, for some parents, the risks we report may outweigh the potential benefits. This information may help parents seeking guidance to make an informed decision.

Entities:  

Mesh:

Year:  2000        PMID: 10617731

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  28 in total

1.  [Errors and risks in ambulatory operations: circumcision].

Authors:  E Stark; J Steffens
Journal:  Urologe A       Date:  2003-08       Impact factor: 0.639

Review 2.  Neonatal Herpes Simplex Virus Type 1 Infection and Jewish Ritual Circumcision With Oral Suction: A Systematic Review.

Authors:  Brian F Leas; Craig A Umscheid
Journal:  J Pediatric Infect Dis Soc       Date:  2014-07-23       Impact factor: 3.164

3.  Should newborns be circumcised? No.

Authors:  Deirdre Andres
Journal:  Can Fam Physician       Date:  2007-12       Impact factor: 3.275

4.  Routine circumcision: the opposing view.

Authors:  Andrew E Macneily
Journal:  Can Urol Assoc J       Date:  2007-11       Impact factor: 1.862

5.  Circumcision for all: the pro side.

Authors:  Anne-Marie Houle
Journal:  Can Urol Assoc J       Date:  2007-11       Impact factor: 1.862

Review 6.  [Current and practice-relevant news from pediatric urology].

Authors:  R Stein; A Schröder; M Goepel
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

7.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

8.  Foreskin management: Survey of Canadian pediatric urologists.

Authors:  Peter D Metcalfe; Remon Elyas
Journal:  Can Fam Physician       Date:  2010-08       Impact factor: 3.275

Review 9.  Complications of circumcision in male neonates, infants and children: a systematic review.

Authors:  Helen A Weiss; Natasha Larke; Daniel Halperin; Inon Schenker
Journal:  BMC Urol       Date:  2010-02-16       Impact factor: 2.264

10.  Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males.

Authors:  Stephanie L Sansom; Vimalanand S Prabhu; Angela B Hutchinson; Qian An; H Irene Hall; Ram K Shrestha; Arielle Lasry; Allan W Taylor
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.